The correlation between blood biomarkers and metabolic desease

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100044786

Enrollment

Unknown

Registered

2021-03-27

Start date

2021-06-01

Completion date

Unknown

Last updated

2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Desease

Interventions

Normal group

Type 2 diabetes group:None

Eligibility

Sex/Gender

All

Age

20 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age between 20 and 75; 2. Meet the diagnostic criteria for metabolic desease.

Exclusion criteria

Exclusion criteria: 1. Type 1 diabetes; 2. Malignant tumor; 3. Combined with severe gastrointestinal diseases (including peptic ulcer, hepatitis, inflammatory bowel disease, intestinal tuberculosis, severe diarrhea, constipation, etc.); 4. Severe liver, kidney and heart insufficiency, recent combined infection, fever, and rheumatic immune diseases; 5. Those who do not cooperate.

Design outcomes

Primary

Measure	Time frame
Biomarker Concentration;	—

Countries

China

Contacts

Public ContactYong Xu

The Affiliated Hospital of Southwest Medical University

xywyll@swmu.edu.cn+86 13980255895

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026